BEST study: one-year descriptive follow-up of bevacizumab treatment in hereditary haemorrhagic telangiectasia post-BABH interventional study
最佳研究：贝伐珠单抗治疗遗传性出血性毛细血管扩张症患者（BABH 干预研究后）的一年描述性随访
期刊:Therapeutic Advances in Hematology
影响因子:3.1
doi:10.1177/20406207241300828
Dupuis-Girod, Sophie; Decullier, Evelyne; Rivière, Sophie; Lavigne, Christian; Grobost, Vincent; Leguy-Seguin, Vanessa; Maillard, Hélène; Chinet, Thierry; Fargeton, Anne-Emmanuelle; Guilhem, Alexandre; Hermann, Ruben
